Cox Capital Management
ABBV icon

Cox Capital Management’s AbbVie ABBV Stock Holding History

Cox Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.29M Sell
12,558
-82
-0.6% -$21K 1.84% 16
2026
Q2 		$3.18M Buy
+12,640
New +$2.72M 1.77% 18
2024
Q3 		– Sell
-8,777
Closed -$1.51M – 67
2024
Q2 		$1.51M Sell
8,777
-765
-8% -$127K 0.91% 42
2024
Q1 		$1.74M Sell
9,542
-532
-5% -$91.7K 1.07% 41
2023
Q4 		$1.56M Sell
10,074
-529
-5% -$77.1K 1.02% 40
2023
Q3 		$1.58M Buy
10,603
+819
+8% +$120K 1.11% 39
2023
Q2 		$1.32M Sell
9,784
-492
-5% -$72.1K 0.97% 42
2023
Q1 		$1.64M Sell
10,276
-9,605
-48% -$1.47M 1.18% 40
2022
Q4 		$3.21M Buy
19,881
+663
+3% +$102K 2.09% 14
2022
Q3 		$2.58M Buy
19,218
+211
+1% +$30.3K 1.87% 24
2022
Q2 		$2.91M Buy
19,007
+172
+0.9% +$26.3K 1.99% 20
2022
Q1 		$3.05M Sell
18,835
-4
-0% -$581 1.92% 20
2021
Q4 		$2.55M Sell
18,839
-7,854
-29% -$928K 1.51% 28
2021
Q3 		$2.88M Sell
26,693
-209
-0.8% -$23.9K 1.94% 17
2021
Q2 		$3.03M Sell
26,902
-651
-2% -$73.3K 2.03% 14
2021
Q1 		$2.98M Sell
27,553
-8,720
-24% -$933K 2.07% 13
2020
Q4 		$3.89M Buy
36,273
+1,157
+3% +$111K 2.96% 3
2020
Q3 		$3.08M Buy
35,116
+336
+1% +$31.6K 2.71% 5
2020
Q2 		$3.42M Buy
34,780
+1,264
+4% +$111K 3.37% 2
2020
Q1 		$2.97M Hold
33,516
– – 2.59% 5
2019
Q4 		$2.97M Buy
33,516
+92
+0.3% +$7.64K 2.7% 5
2019
Q3 		$2.53M Buy
33,424
+246
+0.7% +$16.9K 2.47% 10
2019
Q2 		$2.41M Buy
33,178
+10,921
+49% +$858K 2.45% 12
2019
Q1 		$1.79M Buy
22,257
+730
+3% +$59.7K 1.94% 19
2018
Q4 		$1.85M Buy
21,527
+749
+4% +$65.9K 2.17% 15
2018
Q3 		$1.96M Buy
20,778
+571
+3% +$54.1K 2.09% 15
2018
Q2 		$1.87M Buy
+20,207
New +$1.97M 2.26% 13

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $40B AUM 30.45% 1-Year Est. Return
Cardano Risk Management
Cardano Risk Management Rotterdam, Netherlands $18.2B AUM 38.97% 1-Year Est. Return
Sepio Capital
Sepio Capital Salt Lake City, Utah $2.5B AUM 20.77% 1-Year Est. Return

Cox Capital Management's ABBV Position: Q3 2026 in Review

Cox Capital Management reduced its AbbVie (ABBV) stake by 0.65% in Q3 2026, selling an estimated $21K and leaving 12,558 shares worth $3.29M. The position accounts for 1.84% of the portfolio, ranked #16.

Cox Capital Management first reported a position in ABBV in Q2 2018 and has held it in 27 quarters since. The position peaked at $3.89M in Q4 2020. 1,913 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Cox Capital Management held 12,558 shares of AbbVie worth $3.29M as of Q3 2026.
  • Cox Capital Management sold 82 AbbVie shares in Q3 2026, an estimated $21K.
  • AbbVie made up 1.84% of Cox Capital Management's portfolio in Q3 2026, its #16 holding.
  • Cox Capital Management first reported a position in AbbVie in Q2 2018 and has held it in 27 quarters since.
  • Cox Capital Management's AbbVie position peaked at $3.89M in Q4 2020.
  • 1,913 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Cox Capital Management's 13F filing for Q3 2026, filed 7 Oct 2026.